Femasys Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Femasys Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- Femasys Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-09-30 was $0.00.
- Femasys Inc. stock issued during period, value, stock options exercised for the quarter ending 2022-06-30 was $16.15K, a 84.18% decline year-over-year.
- Femasys Inc. stock issued during period, value, stock options exercised for the quarter ending 2021-12-31 was $14.40K, a 85.25% decline year-over-year.
- Femasys Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $16.15K, a 87.24% decline from fiscal 2021.
- Femasys Inc. stock issued during period, value, stock options exercised for fiscal 2021 was $126.55K, a 17.40% decline from fiscal 2020.
- Femasys Inc. stock issued during period, value, stock options exercised for fiscal 2020 was $153.20K.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $16.15K 10-K · filed 2024-03-28 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2022-06-30 | $16.15K 10-Q · filed 2023-08-10 | |
| 2021-12-31 | $14.40K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-07-24 | $126.55K 10-K/A · filed 2023-07-24 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-12 | $209.79K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-06-30 | $102.09K 10-Q · filed 2022-08-10 | $212.54K derived: sum of 4 quarters · filed 2022-08-10 |
| 2021-03-31 | $10.05K 10-Q · filed 2022-05-11 | $110.45K derived: sum of 4 quarters · filed 2022-05-11 |
| 2020-12-31 | $97.65K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | $153.20K 10-K · filed 2022-03-24 |
| 2020-09-30 | $2.75K 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| ACCURAY INC (ARAY) | United States | $0.027B | -0.63 |
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |